A 212 page business report
NOTE! The report below has been superceded by Report #S190, January 2012
Surgical Sealants 2007
Worldwide Surgical Sealants, Glues and Wound Closure Market, 2007-2011
· 212 pages · 63 Exhibits · 52 Company Profiles · Report #S145 · Published Feb. 2007
This report details the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, from tapes, sutures and staples to hemostats, fibrin sealants/glues and medical adhesives. The report details current clinical and technology developments in this huge and rapidly growing worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.
This report is a market and technology assessment and forecast of products in wound closure. The report details the current and emerging products, technologies and markets involved in wound closure and sealing using sutures and staples, tapes, hemostats, fibrin and sealant products and medical adhesives. The report provides a worldwide current and annual forecast to 2011 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade. The report provides specific forecasts and shares of the worldwide market by segment for the U.S., Europe (United Kingdom, German, France, Italy, BeNeLux), Latin America, Japan and Rest of World.
The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies.
The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.
Table of Contents
Section 1: CLINICAL NEED, CASELOAD, AND PROCEDURE VOLUME
1.1 Anatomy and Physiology of Tissue Repair
1.2 The Skin
1.3 Internal Tissues and Organs
1.4 Wound Classification and Types
1.6 The Role of Modern Sealant, Securement and Hemostatic Products in Surgery
Section 2: SCIENCE, TECHNOLOGY, DEVELOPMENT, CLINICAL AND REGULATORY CHALLENGES
2.1 Tissue Healing
2.2 Product Development
2.3 Development Timelines
2.4 Cost Effectiveness
2.5 Regulatory challenges
Section 3: PRODUCTS, TECHNOLOGIES, AND FORECAST OPPORTUNITY
3.2 Development Timeline
3.3 Sutures and Staples
3.6 Fibrin and other Sealant Products
3.7 Post-Surgical Adhesion Prevention
3.8 Wound Closure and Securement Markets: Global and Regional Analysis
3.9 Worldwide Markets By Country and Segment
Section 4: Company Profiles
4.1 Advanced Medical Solutions plc
4.2 Angiotech Pharmaceuticals Inc
4.3 Anika Therapeutics Inc.
4.4 ARC Pharmaceuticals
4.5 Baxter International Inc.
4.6 Berlin Heart AG
4.7 Biocoral Inc.
4.9 Biomet Inc.
4.10 B. Braun Melsungen AG
4.11 Chemence Limited
4.12 Closure Medical Corporation
4.13 Collagen Matrix Inc.
4.14 Confluent Surgical Inc.
4.15 CryoLife Inc.
4.16 Consortium Service Management Group (CSMG)
4.17 CuraMedical BV
4.18 Ethicon (Johnson & Johnson)
4.20 FibroGen, Inc.
4.21 Fidia Advanced Biopolymers
4.22 Focal Inc. (Genzyme Biosurgery)
4.23 FzioMed Inc.
4.24 GEM srl
4.25 Genzyme Biosurgery Inc.
4.26 Glustitch Inc.
4.27 Haemacure Corporation
4.28 Harvest Technologies Corporation
4.29 HemCon, Inc.
4.30 Incisive Surgical, Inc.
4.31 Integra Life Sciences Holdings Corp.
4.32 Kensey Nash Corporation
4.33 King Pharmaceuticals
4.34 Lifecore Biomedical, Inc.
4.35 Marine Polymer Technologies
4.36 Medafor, Inc.
4.37 Nycomed Pharma
4.38 Omrix Biopharmaceuticals Inc.
4.39 Organogenesis Inc.
4.41 Pharming Group NV
4.44 Smith & Nephew plc
4.45 Spiration Inc.
4.46 Synovis Life Technologies
4.47 Thermogenesis Corporation
4.48 Tissuemed Ltd
4.49 Tyco International Inc.
4.50 US Surgical Corp.
4.52 ZLB Behring
APPENDIX: LIST OF COMPANIES
List of Exhibits
Exhibit ES-1: Recent Acquisitions in the Securement Segment
Exhibit ES-2: Introduction of New Securement Technologies to the U.S. Market
Exhibit ES-3: Definition of Surgical Closure and Securement Products
Exhibit ES-4: Incidence of Two Example Surgical Procedures with High Requirement for Adjunctive Products for Surgical Closure and Securement
Exhibit ES-5: U.S. FDA Approved Uses of Sealants, Glues, and Hemostats
Exhibit ES-6: Synthetic and Biological Sealant Competitors (Non-Fibrin Sealants)
Exhibit ES-7: Selected High Strength Adhesive Companies and Their Strategies
Exhibit ES-8: Selected Sealant Product Companies and Their Strategies
Exhibit ES-9: Worldwide Growth in the Securement and Closure Market, 2006-2011
Exhibit 1-1: Skin Structure Illustrating Major Organelles and Skin Layers
Exhibit 1-2: Classification of Wounds by Morphology
Exhibit 1-3: Severity Classification of Wounds
Exhibit 1-4: Wound classification by Etiology
Exhibit 1-5: Incidence of Different Wound Types
Exhibit 1-6: Criteria for Adjunctive Use of Hemostats, Sealants, Glues and Adhesion Prevention Products in Surgery
Exhibit 1-7: Surgical Procedures with Potential for the Use of Hemostats, Sealants, Glues and Adhesion Prevention Products
Exhibit 1-8: Potential for Cardiovascular Applications, Incidences of Applicable Surgical Disorders, 2006
Exhibit 1-9: Potential for Neurological Applications, Incidences of Applicable Disorders (000s), 2006
Exhibit 1-10: Potential for Orthopedic Applications, Numbers of Major Surgical Interventions, 2006
Exhibit 1-11: Potential for Urological Applications, Incidence of Applicable Disorders, 2006
Exhibit 1-12: Potential for Dermal Repair, Incidence of Applicable Disorders
Exhibit 1-13: Applications of Fibrin and Other Sealants
Exhibit 1-14: Surgical Procedures Using Fibrin and Other Sealant Products (2006-2011)
Exhibit 1-15: Surgical Indications for High Strength Glues (Europe - 2006)
Exhibit 2-1: Factors That Affect Wound Healing
Exhibit 2-2: Timescales for Development of Closure and Sealant Products
Exhibit 2-3: Variables Associated With Clinical Evaluation of Closure and Securement, and Related Products
Exhibit 3-1: Companies Commercializing Technologies in the Surgical Suture and Staples Category
Exhibit 3-2: Worldwide Sutures and Staples, Market Forecast, 2006-2011
Exhibit 3-3: Worldwide Suture and Staples Market 2006, Share by Supplier
Exhibit 3-4: Companies Commercializing First Aid Technologies Often Used as Tapes for Closure
Exhibit 3-5: Worldwide Tapes Market Forecast, 2006-2011
Exhibit 3-6: Worldwide Tapes for Closure Market Share, 2006, by Supplier
Exhibit 3-7: Companies Commercializing Technologies in the Hemostat Category
Exhibit 3-8: Worldwide Hemostats Market Forecast, 2006-2011
Exhibit 3-9: Worldwide Hemostats Market Share, 2006, by Supplier
Exhibit 3-10: Companies Commercializing Technologies in the Sealants Category
Exhibit 3-11: Worldwide Sealants Market Forecast, 2006-2011
Exhibit 3-12: Worldwide Sealants Market Share, 2006, by Supplier
Exhibit 3-13: Companies Commercializing Cyanoacrylate-based High Strength Medical Adhesives
Exhibit 3-14: Worldwide High Strength Glues Market Forecast, 2006-2011
Exhibit 3-15: Worldwide High Strength Glues Market Share 2006, by Supplier
Exhibit 3-16: Regulatory Status of Surgical Sealant Products
Exhibit 3-17: Companies Commercializing Technologies in the Post-Operative Adhesion Category
Exhibit 3-18: Worldwide Post Operative Adhesion Prevention Market Forecast, 2006-2011
Exhibit 3-19: Worldwide Post Operative Adhesion Prevention Market Share, 2006, by Supplier
Exhibit 3-20: Size and Growth of Wound Closure and Securement Market, World and Selected Countries, 2006
Exhibit 3-21: Wound Closure Market 2006, by Product Segments: The Major American Countries
Exhibit 3-22: Wound Closure Market 2006, by Product Segments: Japan
Exhibit 3-23: Wound Closure Market 2006, by Product Segments: Major European Countries
Exhibit 3-24: Growth Forecast for Closure and Securement Market, 2006-2011
Exhibit 4-1: Advanced Medical Solutions, selected financial data for 12 months to December 31 2005 and 2004
Exhibit 4-2: Angiotech Pharmaceuticals financial data for the quarter ending September 30th
Exhibit 4-3: Anika Therapeutics selected financial data
Exhibit 4-4: Baxter financial data, $millions
Exhibit 4-5: B Braun financial data, €millions
Exhibit 4-6: CryoLife financial results, 2005
Exhibit 4-7: Johnson & Johnson key financial data; $ millions
Exhibit 4-9: LifeCore Biomedical financial data
Exhibit 4-10: Nycomed topline financial data; € millions
Exhibit 4-11: Omrix topline financial data; $ millions
Exhibit 4-12: Pharming financial data €000s
Note: The report described above has been superceded by Report #S180, January 2012.
Contact: Patrick Driscoll, (949) 859-3401. patrick<at>mediligence<dot>com.
Copyright © 2007 MedMarket Diligence, LLC. All rights reserved.
MedMarket Diligence Reports